share_log

Lake Street Assumes Biolase at Buy, Announces Price Target of $1.5

Lake Street Assumes Biolase at Buy, Announces Price Target of $1.5

Lake Street 假设 Biolase 处于买入状态,宣布目标价为 1.5 美元
Benzinga Real-time News ·  2023/01/20 08:58

Lake Street analyst Frank Takkinen assumes Biolase (NASDAQ:BIOL) with a Buy rating and announces Price Target of $1.5.

Lake Street分析师Frank Takkinen假设Biolase(纳斯达克:BIOL)的评级为买入,并宣布目标价为1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发